Nahdi Medical Company
Nahdi Medical Company scores highest on Anchor (81) and lowest on Price (33). Its PosiPenta is 58.55 out of 100, around the middle of similar companies.
Compared with similar companies in the Healthcare sector in Saudi Arabia.
The five pillars
Details
PPrice
| P/E ratio | 13.53 |
| P/B ratio | 4.24 |
EEarnings
| Trailing EPS | ₹153.42 |
| Forward EPS | ₹178.49 |
NNitro
| Price | 2076.02 |
| 52-week high | 3060.87 |
| 52-week low | 2053.24 |
| Fall from 52-week high | 32.2% |
TTorque
| Return on equity (ROE) | 30.31% |
| Debt-to-equity | 0.70 |
AAnchor
| Beta (price swings) | 0.11 |
| Market cap | ₹26,988 Cr |
| Insider holding | 45.00% |
| Dividend yield | 6.09% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Nahdi Medical Company's PosiPenta score?
Nahdi Medical Company's PosiPenta is 58.55 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Nahdi Medical Company?
Anchor (stability and dividends), with a score of 81 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Nahdi Medical Company?
Price (valuation), with a score of 33 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.